Table 2.

Distribution of various characteristics before and after start of antiretroviral therapy (ART) among patients.

Characteristics before starting ART			Characteristics after starting ART
	Number	Percentage		Number	Percentage
Functional status (n=285)			Functional status (n=240)
Ambulatory	51	17.9	Ambulatory	1	0.4
Bedridden	6	2.1	Bedridden	1	0.4
Working	228	80.0	Working	238	99.2
Pattern of substance usage (n=285)			Pattern of substance usage (n=285)
Tobacco chewing	13	4.6	Tobacco chewing	14	4.9
Smoking	32	11.2	Smoking	15	5.3
Alcohol consumption	62	21.7	Alcohol consumption	22	7.7
Opportunistic infections present (n=285)			Opportunistic infections present (n=285)
Extra pulmonary tuberculosis	34	11.9	Pulmonary tuberculosis	15	5.3
Pulmonary tuberculosis	28	9.8	Extra pulmonary tuberculosis	9	3.2
Candidiasis	5	1.7	Cytomegalovirus infection	2	0.7
Pneumocystis jiroveci pneumonia	4	1.4	Toxoplasmosis	2	0.7
Cryptococcal infections	2	0.7	Others∗∗	2	0.7
Toxoplasmosis	2	0.7
Others∗	3	1.0
BMI (Kg per sq.mtrs) of patients before starting ART (n=257)			BMI of patients after 60 months of starting ART (n=67)
Under weight	87	33.9	Under weight	19	28.4
Normal weight	112	43.6	Normal weight	23	34.3
Over weight	25	9.7	Over weight	16	23.9
Obese	33	12.8	Obese	9	13.4
Clinical staging of HIV patients before starting ART (n=285)			Clinical staging of HIV patients after 60 months of starting ART (n=90)
Stage 1	172	60.3	Stage 1	75	83.3
Stage 2	18	6.3	Stage 2	6	6.7
Stage 3	27	9.5	Stage 3	5	5.6
Stage 4	68	23.9	Stage 4	4	4.4
Mean CD4 count (cells/cu.mm) before starting ART (n=285)	381.4±235.9		Mean CD4 count (cells/cu.mm) after 60 months of starting ART (n=62)	596±216.7

∗Cytomegalovirus infection 1, recurrent respiratory infections 1, and cellulitis 1.

∗∗Cryptococcal infections 1 and skin rashes 1.